Skip to main content
Top
Published in: Malaria Journal 1/2013

Open Access 01-12-2013 | Research

Case investigation and reactive case detection for malaria elimination in northern Senegal

Authors: Megan Littrell, Gnagna Dieng Sow, Algaye Ngom, Mady Ba, Balla Mbacke Mboup, Yakou Dieye, Boniface Mutombo, Duncan Earle, Richard W Steketee

Published in: Malaria Journal | Issue 1/2013

Login to get access

Abstract

Background

Given progress in malaria control in recent years, many control programmes in sub-Saharan Africa will soon be required to strengthen systems for surveillance in order to further drive transmission to zero. Yet few practical experiences are available to guide control programmes in designing surveillance system components in low transmission, pre-elimination, and elimination phases.

Methods

A malaria case investigation programme was piloted for 12 weeks in 2012 in Richard Toll district of northern Senegal. Malaria infections (N = 110) were identified through facility-based passive case detection and investigated within three days. Rapid diagnostic tests (RDT) and a brief questionnaire were administered to 5,520 individuals living within the index case compound or within five neighbouring compounds.

Results

In comparison with family and neighbours, index cases were more likely to be male, age 15–49, and to report travel within the past 15 days that entailed an overnight stay. Twenty-three (0.4%) of family/neighbours were RDT-positive. Potential risk factors for infection among family and neighbours were examined, including: sex, age, occupation, travel history, bed net usage, and residence (index vs neighbouring compound). Adjusting for all factors, relative risk (RR) of infection was associated with residence in the index case household (RR = 3.18, p < 0.05) and recent travel, including travel to Dakar (RR = 19.93, p < 0.001), travel within the region (RR = 9.57, p < 0.01), and to other regions in Senegal (RR = 94.30, p < 0.001). Recent fever among RDT-positive family/neighbours was uncommon (30%). Modifications to testing criteria were examined to optimize the efficiency of secondary case investigations in this population. Limiting blood testing to residents of the index case compound and neighbours with recent travel or fever would have identified 20/23 (87%) of the infections through testing 1,173 individuals. Information on the remaining three infections suggests that additional screening for boarding school attendees may facilitate identification of all cases.

Conclusions

The primary risk factor for malaria infection in the low transmission district of Richard Toll is travel. Additional intervention and monitoring strategies to target travellers at risk of malaria infection are needed in this region. Optimizing case investigation with specific targeted testing and treatment of at-risk family and neighbours strengthens the systems needed for continued progress towards malaria elimination in northern Senegal.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ndiaye S, Ayad M: Enquête Nationale sur le Paludisme au Sénégal 2008–2009. Edited by: Calverton MD. 2009, Senegal: Centre de Recherche pour le Développement Humain [Senegal] and ICF Macro Ndiaye S, Ayad M: Enquête Nationale sur le Paludisme au Sénégal 2008–2009. Edited by: Calverton MD. 2009, Senegal: Centre de Recherche pour le Développement Humain [Senegal] and ICF Macro
2.
go back to reference Ndiaye S, Ayad M: Ministère de la Santé et de la Prévention Médicale Centre de Recherche pour le Développement Humain Dakar, Sénégal, ORC Macro: Enquête démographique et santé à indicateurs multiples au Sénégal (EDS-MICS) 2010–2011. 2012, Calverton, MD: ANSD and ICF International Ndiaye S, Ayad M: Ministère de la Santé et de la Prévention Médicale Centre de Recherche pour le Développement Humain Dakar, Sénégal, ORC Macro: Enquête démographique et santé à indicateurs multiples au Sénégal (EDS-MICS) 2010–2011. 2012, Calverton, MD: ANSD and ICF International
3.
go back to reference Mouzin E, Thior PM, Diouf MB: Sambou: RBM progress & impact series: focus on Senegal. 2010, Geneva: World Health Organization Mouzin E, Thior PM, Diouf MB: Sambou: RBM progress & impact series: focus on Senegal. 2010, Geneva: World Health Organization
4.
go back to reference Sénégal PNLP: Plan stratégique national 2011–2015. 2010, Dakar: Sénégal Sénégal PNLP: Plan stratégique national 2011–2015. 2010, Dakar: Sénégal
5.
go back to reference WHO: Disease surveillance for malaria control: an operational manual. 2012, Geneva: World Health Organization WHO: Disease surveillance for malaria control: an operational manual. 2012, Geneva: World Health Organization
6.
go back to reference WHO: Disease surveillance for malaria elimination: an operational manual. 2012, Geneva: World Health Organization WHO: Disease surveillance for malaria elimination: an operational manual. 2012, Geneva: World Health Organization
7.
go back to reference Sturrock HJ, Hsiang MS, Cohen JM, Smith DL, Greenhouse B, Bousema T, Gosling RD: Targeting asymptomatic malaria infections: active surveillance in control and elimination. PLoS Med. 2013, 10: e1001467-10.1371/journal.pmed.1001467.PubMedCentralCrossRefPubMed Sturrock HJ, Hsiang MS, Cohen JM, Smith DL, Greenhouse B, Bousema T, Gosling RD: Targeting asymptomatic malaria infections: active surveillance in control and elimination. PLoS Med. 2013, 10: e1001467-10.1371/journal.pmed.1001467.PubMedCentralCrossRefPubMed
8.
go back to reference Sanders K, Gueye CS, Phillips AA, Gosling R: Active case detection for malaria elimination: a confusion of acronyms and definitions. Malar Chemother Control Elimination. 2012, 1: 1-5.CrossRef Sanders K, Gueye CS, Phillips AA, Gosling R: Active case detection for malaria elimination: a confusion of acronyms and definitions. Malar Chemother Control Elimination. 2012, 1: 1-5.CrossRef
9.
go back to reference Pampana E: A textbook of malaria eradication. 1963, London: Oxford University Press Pampana E: A textbook of malaria eradication. 1963, London: Oxford University Press
10.
go back to reference Moonen B, Cohen JM, Snow RW, Slutsker L, Drakeley C, Smith DL, Abeyasinghe RR, Rodriguez MH, Maharaj R, Tanner M, Targett G: Operational strategies to achieve and maintain malaria elimination. Lancet. 2010, 376: 1592-1603. 10.1016/S0140-6736(10)61269-X.PubMedCentralCrossRefPubMed Moonen B, Cohen JM, Snow RW, Slutsker L, Drakeley C, Smith DL, Abeyasinghe RR, Rodriguez MH, Maharaj R, Tanner M, Targett G: Operational strategies to achieve and maintain malaria elimination. Lancet. 2010, 376: 1592-1603. 10.1016/S0140-6736(10)61269-X.PubMedCentralCrossRefPubMed
11.
go back to reference Abeyasinghe RR, Galappaththy GNL, Smith Gueye C, Kahn JG, Feachem RGA: Malaria control and elimination in Sri Lanka: documenting progress and success factors in a conflict setting. PLoS One. 2012, 7: e43162-10.1371/journal.pone.0043162.PubMedCentralCrossRefPubMed Abeyasinghe RR, Galappaththy GNL, Smith Gueye C, Kahn JG, Feachem RGA: Malaria control and elimination in Sri Lanka: documenting progress and success factors in a conflict setting. PLoS One. 2012, 7: e43162-10.1371/journal.pone.0043162.PubMedCentralCrossRefPubMed
12.
go back to reference Kunene S, Phillips AA, Gosling R, Kandula D, Novotny JM: A national policy for malaria elimination in Swaziland: a first for sub-Saharan Africa. Malar J. 2011, 10: 313-10.1186/1475-2875-10-313.PubMedCentralCrossRefPubMed Kunene S, Phillips AA, Gosling R, Kandula D, Novotny JM: A national policy for malaria elimination in Swaziland: a first for sub-Saharan Africa. Malar J. 2011, 10: 313-10.1186/1475-2875-10-313.PubMedCentralCrossRefPubMed
13.
go back to reference Sturrock HJW, Novotny JM, Kunene S, Dlamini S, Zulu Z, Cohen JM, Hsiang MS, Greenhouse B, Gosling RD: Reactive case detection for malaria elimination: real life experience from an ongoing program in Swaziland. PLoS ONE. 2013, 8: e63830-10.1371/journal.pone.0063830.PubMedCentralCrossRefPubMed Sturrock HJW, Novotny JM, Kunene S, Dlamini S, Zulu Z, Cohen JM, Hsiang MS, Greenhouse B, Gosling RD: Reactive case detection for malaria elimination: real life experience from an ongoing program in Swaziland. PLoS ONE. 2013, 8: e63830-10.1371/journal.pone.0063830.PubMedCentralCrossRefPubMed
14.
go back to reference ZMCP: Malaria elimination in Zanzibar: A feasibility assessment. 2009, Zanzibar: ZMCP ZMCP: Malaria elimination in Zanzibar: A feasibility assessment. 2009, Zanzibar: ZMCP
15.
go back to reference The malERA Consultative Group on Monitoring, Evaluation, and Surveillance: A research agenda for malaria elimination: monitoring, evaluation, and surveillance. PLoS Med. 2011, 8 (1): e1000400-CrossRef The malERA Consultative Group on Monitoring, Evaluation, and Surveillance: A research agenda for malaria elimination: monitoring, evaluation, and surveillance. PLoS Med. 2011, 8 (1): e1000400-CrossRef
16.
go back to reference Cotter C, Sturrock HJW, Hsiang MS, Lui J, Phillips AA, Hwang J, Gueye CS, Fullman N, Gosling RD, Feachem RGA: The changing epidemiology of malaria elimination: new strategies for new challenges. Lancet. 2013, 382: 900-911. 10.1016/S0140-6736(13)60310-4.CrossRefPubMed Cotter C, Sturrock HJW, Hsiang MS, Lui J, Phillips AA, Hwang J, Gueye CS, Fullman N, Gosling RD, Feachem RGA: The changing epidemiology of malaria elimination: new strategies for new challenges. Lancet. 2013, 382: 900-911. 10.1016/S0140-6736(13)60310-4.CrossRefPubMed
17.
go back to reference Baltzell KA, Shakely D, Hsiang M, Kemere J, Ali AS, Bjorkman A, Martensson A, Omar R, Elfving K, Msellem M, Aydin-Schmidt B, Rosenthal PJ, Greenhouse B: Prevalence of PCR detectable malaria infection among febrile patients with a negative Plasmodium falciparum specific rapid diagnostic test in Zanzibar. Am J Trop Med Hyg. 2013, 88: 289-291. 10.4269/ajtmh.2012.12-0095.PubMedCentralCrossRefPubMed Baltzell KA, Shakely D, Hsiang M, Kemere J, Ali AS, Bjorkman A, Martensson A, Omar R, Elfving K, Msellem M, Aydin-Schmidt B, Rosenthal PJ, Greenhouse B: Prevalence of PCR detectable malaria infection among febrile patients with a negative Plasmodium falciparum specific rapid diagnostic test in Zanzibar. Am J Trop Med Hyg. 2013, 88: 289-291. 10.4269/ajtmh.2012.12-0095.PubMedCentralCrossRefPubMed
18.
go back to reference Okell LC, Bousema T, Griffin JT, Ouedraogo AL, Ghani AC, Drakeley CJ: Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun. 2012, 3: 1237-PubMedCentralCrossRefPubMed Okell LC, Bousema T, Griffin JT, Ouedraogo AL, Ghani AC, Drakeley CJ: Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun. 2012, 3: 1237-PubMedCentralCrossRefPubMed
19.
go back to reference Yukich JO, Taylor C, Eisele TP, Reithinger R, Nauhassenay H, Berhane Y, Keating J: Travel history and malaria infection risk in a low-transmission setting in Ethiopia: a case control study. Malar J. 2013, 12: 33-10.1186/1475-2875-12-33.PubMedCentralCrossRefPubMed Yukich JO, Taylor C, Eisele TP, Reithinger R, Nauhassenay H, Berhane Y, Keating J: Travel history and malaria infection risk in a low-transmission setting in Ethiopia: a case control study. Malar J. 2013, 12: 33-10.1186/1475-2875-12-33.PubMedCentralCrossRefPubMed
20.
21.
go back to reference Sinclair D, Zani B, Donegan S, Olliaro P, Garner P: Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database Syst Rev. 2009, 8: CD007483 Sinclair D, Zani B, Donegan S, Olliaro P, Garner P: Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database Syst Rev. 2009, 8: CD007483
22.
go back to reference WHO GMP: Updated WHO policy recommendation: single dose primaquine as a gametocytocide in Plasmodium falciparum malaria. 2012, Geneva: WHO WHO GMP: Updated WHO policy recommendation: single dose primaquine as a gametocytocide in Plasmodium falciparum malaria. 2012, Geneva: WHO
23.
go back to reference The malERA Consultative Group on Diagnostics and Diagnosis: A research agenda for malaria eradication: diagnostics and drugs. PLoS Med. 2011, 8: e1000396-CrossRef The malERA Consultative Group on Diagnostics and Diagnosis: A research agenda for malaria eradication: diagnostics and drugs. PLoS Med. 2011, 8: e1000396-CrossRef
24.
go back to reference Hoyer S, Nguon S, Kim S, Habib N, Khim N, Sum S, Christophel EM, Bjorge S, Thomson A, Kheng S, Chea N, Yok S, Top S, Ros S, Sophal U, Thompson MM, Mellor S, Ariey F, Witkowski B, Yeang C, Yeung S, Duong S, Newman RD, Menard D: Focused screening and treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. Falciparum, Pailin, Cambodia. PLoS One. 2012, 7: e45797-10.1371/journal.pone.0045797.PubMedCentralCrossRefPubMed Hoyer S, Nguon S, Kim S, Habib N, Khim N, Sum S, Christophel EM, Bjorge S, Thomson A, Kheng S, Chea N, Yok S, Top S, Ros S, Sophal U, Thompson MM, Mellor S, Ariey F, Witkowski B, Yeang C, Yeung S, Duong S, Newman RD, Menard D: Focused screening and treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. Falciparum, Pailin, Cambodia. PLoS One. 2012, 7: e45797-10.1371/journal.pone.0045797.PubMedCentralCrossRefPubMed
25.
go back to reference Buckee CO, Wesolowski A, Eagle NN, Hansen E, Snow RW: Mobile phones and malaria: modeling human and parasite travel. Travel Med Infect Dis. 2013, 11: 15-22. 10.1016/j.tmaid.2012.12.003.PubMedCentralCrossRefPubMed Buckee CO, Wesolowski A, Eagle NN, Hansen E, Snow RW: Mobile phones and malaria: modeling human and parasite travel. Travel Med Infect Dis. 2013, 11: 15-22. 10.1016/j.tmaid.2012.12.003.PubMedCentralCrossRefPubMed
Metadata
Title
Case investigation and reactive case detection for malaria elimination in northern Senegal
Authors
Megan Littrell
Gnagna Dieng Sow
Algaye Ngom
Mady Ba
Balla Mbacke Mboup
Yakou Dieye
Boniface Mutombo
Duncan Earle
Richard W Steketee
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2013
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-12-331

Other articles of this Issue 1/2013

Malaria Journal 1/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.